市場調查報告書
商品編碼
1305213
全球生藥市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測Global Eubiotics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
在2023-2030年的研究期內,預計全球生藥市場需求將從2022年的81.2億美元成長到2030年的近169.9億美元,複合年成長率為8.55%。在產量方面,2022年的市場容量為XX個單位,預計到2030年將達到XX個單位,2023-2030年的複合年成長率為XX%。
Eubiotics是用於描述促進動物消化系統微生物平衡和健康的物質或技術的術語。它是指使用飼料添加劑,如益生菌、益生元、有機酸和酶來改善動物的健康和性能。在畜牧業中使用益生菌可減少飼料中抗生素和其他化學添加劑的使用,因為它們提供了一種天然、安全的替代品。它們還可用於改善動物健康、福利和生產力,以及減少疾病的發生和獸醫干涉的需要。
全球對肉類和動物產品的需求不斷成長,推動了動物飼料中對生物素的需求。生物素有助於改善動物健康和提高生產率,從而提高肉類和乳製品的品質和數量。許多國家限制抗生素生長促進劑在動物飼料中的使用,導致擴大使用生物素作為天然替代品來改善動物健康和提高動物性能。消費者和動物福利組織對抗生素在動物飼料中的使用及其對動物健康和福利的潛在影響的認知不斷提高,推動了對生物素的需求。人們對食品安全和品質的日益關注推動了動物飼料中生物素的需求。生物素被認為是抗生素的安全天然替代品,使用生物素可提高肉類和動物產品的品質和安全性。微膠囊技術和奈米技術等新型先進生物素生產技術的發展推動了生物素市場的成長。中國、印度和巴西等經濟不斷成長的國家對肉類和動物產品的需求不斷增加,推動了動物飼料中益生元的需求。這些地區不斷成長的需求預計將在未來幾年推動全球動物營養素市場的成長。
本報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於在全球範圍內清晰地了解行業結構並評估競爭吸引力。此外,這些工具還對全球益生菌市場的各個細分市場進行了全面評估。保健食品行業的成長和趨勢為本研究提供了全面的方法。
本部分通過分析國家和地區層面的細分市場提供詳細數據,從而幫助戰略家確定相應產品或服務的目標人群以及即將到來的機會。
本部分涵蓋了區域前景,突出了北美、歐洲、亞太、拉丁美洲、中東和非洲地區對益生元市場當前和未來的需求。此外,報告還重點分析了所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場中主要企業的綜合概況以及全球競爭格局的深入分析。益生菌市場的主要參與者包括DSM、Novozymes、Kemin Industries Inc.、Roquette Freres、FrieslandCampina、Neospark Drugs and Chemicals Private Limited、ASAHI GROUP HOLDINGS Ltd.、Lesaffre、MSPrebiotics Inc.、ADM、Lallemand Inc.、BEHN MEYER、NOVUS INTERNATIONAL、BENEO、Yara、Cargill Incorporated、BASF SE、Chr. Hansen Holding A/S、ADDCON GmbH。本節包括競爭格局的整體視圖,其中包括各種戰略發展,如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品上市和其他發展。
注-在公司概況中,財務細節和近期發展視情況而定,如果是私營公司則可能不包括在內。
The global demand for Eubiotics Market is presumed to reach the market size of nearly USD 16.99 BN by 2030 from USD 8.12 BN in 2022 with a CAGR of 8.55% under the study period of 2023 - 2030. Regarding volume, the market was calculated XX Units in 2022 and forecast to touch XX Units by 2030 with a CAGR of XX% during 2023 - 2030.
Eubiotics is a term used to describe substances or techniques that promote the balance and well-being of microorganisms in the digestive system of animals. It refers to the use of feed additives, such as probiotics, prebiotics, organic acids, and enzymes, to improve the health and performance of animals. Eubiotics are used in animal husbandry to reduce the use of antibiotics and other chemical additives in feed, as they provide a natural and safe alternative. They are also used to improve animal health, welfare, and productivity, as well as to reduce the incidence of diseases and the need for veterinary interventions.
The growing demand for meat and animal products worldwide is driving the demand for eubiotics in animal feed. Eubiotics help improve animal health and productivity, which leads to better quality and quantity of meat and dairy products. The restriction on antibiotic growth promoters' usage in animal feed in many countries has led to the increased use of eubiotics as a natural alternative to improve animal health and performance. The increasing awareness among consumers and animal welfare organizations about the use of antibiotics in animal feed and its potential impact on animal health and welfare are driving the demand for eubiotics. The rising concerns about food safety and quality are driving the demand for eubiotics in animal feed. Eubiotics are considered safe and natural alternatives to antibiotics, and their use can improve the quality and safety of meat and animal products. The development of new and advanced technologies in the production of eubiotics, such as microencapsulation and nanotechnology, is driving the growth of the eubiotics market. The rising demand for meat and animal products in the growing economies of China, India, and Brazil is driving the demand for eubiotics in animal feed. The increasing demand from these regions is expected to drive the growth of the global eubiotics market in the coming years.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of eubiotics. The growth and trends of Eubiotics Industry provide a holistic approach to this study.
This section of the eubiotics market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Eubiotics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the eubiotics market include DSM, Novozymes, Kemin Industries Inc., Roquette Freres, FrieslandCampina, Neospark Drugs and Chemicals Private Limited, ASAHI GROUP HOLDINGS Ltd., Lesaffre, MSPrebiotics Inc., ADM, Lallemand Inc., BEHN MEYER, NOVUS INTERNATIONAL, BENEO, Yara, Cargill Incorporated, BASF SE, Chr. Hansen Holding A/S, ADDCON GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies